No Detail Found!

Efects of ganciclovir combined with recombinant human interferon-α on clinical eficacy and immune function in children with infectious mononucleosis

Author(s)
Ling Sun Department of Infectious Diseases, Beijing Children’s Hospital Affiliated to Capital Medical University Baoding Hospital, Baoding 071000, Hebei, P.R. China.
Jing Bi Department of Infectious Diseases, Beijing Children’s Hospital Affiliated to Capital Medical University Baoding Hospital, Baoding 071000, Hebei, P.R. China.
Weina Zhen Department of Infectious Diseases, Beijing Children’s Hospital Affiliated to Capital Medical University Baoding Hospital, Baoding 071000, Hebei, P.R. China.
Meiying Wang Department of Laboratory, Baoding Hospital of Traditional Chinese Medicine, Baoding 071000, Hebei, P.R. China.
Haobin Song Department of Infectious Diseases, Beijing Children’s Hospital Affiliated to Capital Medical University Baoding Hospital, Baoding 071000, Hebei, P.R. China.
Abstract
Objective: To evaluate the efects of ganciclovir combined with recombinant human interferon on clinical eficacy and immune function of children with infectious mononucleosis(IM). Methods: This was a retrospective study. Children (n=120) with IM hospitalized in Beijing Children's Hospital Afiliated to Capital Medical University Baoding Hospital from January 2020 to January 2022 were selected and randomly divided into study group and control group((n=60). Patients in the control group were treated with ganciclovir by intravenous infusion, and patients in the study group were given ganciclovir+recombinant human interferon-a1b. The time for eliminating clinical symptoms, the levels of inflammatory cytokines, immune function condition and T-lymphocyte subsets between the two groups were compared and analyzed. Results: After treatment, the time for body temperature returned to normal, time for recovery from cervical lymphadenopathy, time for recovery from hepatosplenomegaly and time for disappearance of angina and oral mucosal congestion in the study group were significantly shorter than those in the control group(p= 0.00); after treatment, the levels of TNF-a and IL-6 in the study group were significantly lower than those in the control group; the indexes of CD3+ and CD8+ in the study group were significantly lower than those in the control group; after treatment, the levels of CD4+ and CD4+/CD8+ in the study group were significantly higher than those in the control group. Conclusion: Ranciclovir combined with recombinant human interferon-a1b, rapid improvements of clinical symptoms, significantly decreased inflammatory cytokines, improved T-lymphocyte function and no significant increase in adverse drug reactions were found in children with IM.
Publication Details
Page(s) 1473-1478
DOI DOI not available
Published Journal: Pakistan Journal of Medical Sciences, Volume: 40, Issue: 7, Year: 2024

Request the full text from PASTIC

Keywords
Treatment, Children, Children, Children, Ganciclovir, Immune function, Recombinant human interferon-a, Infectious mononucleosis
0

Citations

0

Downloads

81

Views